Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Neoplasms Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05538195
What this trial is testing

Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors

Who this might be right for
Gastric CancerColon CancerRectal Cancer+2 more
Chongqing Precision Biotech Co., Ltd 17
Not applicableUnknownNCT05830019
What this trial is testing

Carbon Ion Radiotherapy for Recurrent Pancreatic Cancer Post Surgery

Who this might be right for
Pancreatic Carcinoma
Shanghai Proton and Heavy Ion Center 49
Not applicableUnknownNCT04049461
What this trial is testing

Heterotopic Ossification in Abdominal Incision and Pancreatic Cancer

Who this might be right for
Cancer of PancreasOssification, Heterotopic
Nanjing Medical University 105
Large-scale testing (Phase 3)UnknownNCT01655641
What this trial is testing

Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery

Who this might be right for
Gastric CancerPancreatic CancerHepatocellular Cancer+1 more
Tribhuvan University Teaching Hospital, Institute Of Medicine. 118
Testing effectiveness (Phase 2)Study completedNCT02098239
What this trial is testing

Single Centre Study to Determine the Antibody Response to G17DT in Patients With Advanced Pancreatic Cancer.

Who this might be right for
JaundicePancreatic Cancer
Cancer Advances Inc. 41
Early research (Phase 1)Study completedNCT00739453
What this trial is testing

Dose-escalation Study of OSI-906 and Erlotinib (Tarceva®)

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Inc 95
Testing effectiveness (Phase 2)Study completedNCT01032057
What this trial is testing

Gemcitabine, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery

Who this might be right for
Pancreatic Cancer
Lisette Nixon 114
Not applicableEnded earlyNCT03073473
What this trial is testing

Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers

Who this might be right for
Pancreatic CancerMetastatic Breast CancerMetastatic Lung Cancer+3 more
Cota Inc. 40
Not applicableLooking for participantsNCT05403177
What this trial is testing

Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)

Who this might be right for
Breast CancerColorectal CancerPancreas Cancer+9 more
University Health Network, Toronto 500
Early research (Phase 1)Study completedNCT00056537
What this trial is testing

ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer

Who this might be right for
Non-Small-Cell Lung CarcinomaRenal Cell CarcinomaPancreatic Cancer
Active Biotech AB 44
Not applicableStudy completedNCT00433602
What this trial is testing

Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+5 more
European Organisation for Research and Treatment of Cancer - EORTC 64
Not applicableStudy completedNCT06129812
What this trial is testing

An Exploration of Candidates for Neoadjuvant Treatment in Resectable Pancreatic Cancer

Who this might be right for
Pancreatic CancerNeoadjuvant
Seoul National University Hospital 1,132
Not applicableStudy completedNCT05470166
What this trial is testing

Lidocaine Infusion With ERAS Protocol for Pancreatic Cancer Surgery: Effect on Pain and Patient Immunity.

Who this might be right for
ERASLidocaineCancer of Pancreas+1 more
Alexandria University 30
Not applicableUnknownNCT04783831
What this trial is testing

Biodegradable Pancreatic Stents for the Prevention of Postoperative Pancreatic Fistula After Cephalic Pancreaticoduodenectomy

Who this might be right for
Pancreatic FistulaPancreas NeoplasmStent Disintegration+2 more
Hospital Universitario Virgen de la Arrixaca 60
Early research (Phase 1)Study completedNCT00352131
What this trial is testing

Maytansinoid DM4-Conjugated Humanized Monoclonal Antibody huC242 in Treating Patients With Solid Tumors

Who this might be right for
Non-colorectal CancerPancreatic Cancer
ImmunoGen, Inc. 50
Testing effectiveness (Phase 2)Study completedNCT00042939
What this trial is testing

Irinotecan and Docetaxel With or Without Cetuximab in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Eastern Cooperative Oncology Group 94
Not applicableEnded earlyNCT04311047
What this trial is testing

Preoperative Detection of Lymph Node Metastases in Pancreatic and Periampullary Carcinoma Using USPIO MRI

Who this might be right for
Pancreatic CancerPeriampullary Cancer
Radboud University Medical Center 26
Not applicableUnknownNCT01127815
What this trial is testing

Identify the Clinical Significance and Potential Implications of Peritoneal Washing Cytology (PWC) in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
National Taiwan University Hospital 300
Not applicableStudy completedNCT05547074
What this trial is testing

A New Prognostic Score Model for Pancreatic Ductal Adenocarcinoma

Who this might be right for
Neoplasms Pancreatic
Zhejiang University 302
Testing effectiveness (Phase 2)Looking for participantsNCT07539155
What this trial is testing

Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic Cancer

Who this might be right for
Borderline Resectable/Unresectable Pancreatic CancerNon Metastatic Pancreatic Cancer
University of Arkansas 20
Next Page